Arteris (NASDAQ:AIP) CEO Sells $159,008.85 in Stock
Arteris (NASDAQ:AIP) CEO K. Charles Janac sold 9,009 shares of the company's stock for $159,008.85 on April 2nd under a pre-arranged Rule 10b5-1 plan to cover tax withholding obligations. This transaction reduced his ownership by 4.14% to 208,529 shares. Janac has made numerous other insider sales since January, totaling over $3.7 million.
Arteris (NASDAQ:AIP) COO Sells $28,292.96 in Stock
Arteris (NASDAQ:AIP) COO Laurent Moll sold 1,552 shares worth $28,292.96 on April 6th to cover tax withholding obligations, reducing his stake by 0.55%. The company recently exceeded Q4 earnings and revenue estimates. Analysts currently have a "Hold" rating on the stock with an average price target of $20.17.
Laurent Moll Sells 5,602 Shares of Arteris (NASDAQ:AIP) Stock
Arteris (NASDAQ:AIP) COO Laurent Moll sold 5,602 shares of the company's stock on April 2nd at an average price of $17.65, totaling $98,875.30. This sale, conducted under a Rule 10b5-1 plan, was to cover tax withholding obligations and reduced his position by 1.94%. Despite beating recent quarterly earnings expectations, analysts maintain an average "Hold" rating for Arteris with a $20.17 price target.
Arteris (NASDAQ: AIP) VP sells 3,649 shares to cover RSU taxes
Arteris, Inc.'s VP and General Counsel, Paul L. Alpern, sold 3,649 shares of common stock at $17.6528 per share on April 2, 2026. These transactions were "sell to cover" trades mandated by Arteris’ equity incentive plans to satisfy tax withholding obligations related to restricted stock unit vesting, not discretionary sales. Following these sales, Mr. Alpern still directly holds 86,386 shares of Arteris common stock.
Arteris (AIP) CFO sells 4,870 shares in tax-related Form 4 filing
Arteris (AIP) CFO Nicholas B. Hawkins sold 4,870 shares of common stock on April 2, 2026, for approximately $86,000, in a "sell to cover" transaction to fulfill tax withholding obligations tied to restricted stock unit vesting. These sales were mandatory, not discretionary trades. Following these transactions, Hawkins directly holds 118,614 shares of Arteris common stock.
Arteris (AIP) VP Hawkins sells $85,969 in stock
Nicholas B. Hawkins, VP and CFO of Arteris, Inc., sold 5,870 shares of common stock for $85,969 to cover tax obligations. This sale comes as Arteris shares have surged 205% over the past year. The company recently reported strong Q4 2025 financial results, exceeding revenue and EPS expectations.
Arteris (AIP) COO tax-related sale of 7,154 shares under 10b5-1 plan
Arteris, Inc.'s Chief Operating Officer, Laurent R. Moll, sold 7,154 shares of common stock in open-market transactions at prices between $17.65 and $18.23 per share. These sales were classified as "sell to cover" transactions under a Rule 10b5-1 trading plan adopted on March 12, 2025, primarily to satisfy tax liabilities from restricted stock unit releases, rather than discretionary trades. Following these transactions, Moll directly holds 280,972 shares of Arteris common stock.
Arteris COO Moll sells $127,182 in AIP stock
Arteris, Inc. COO Laurent R. Moll sold a total of $127,182 worth of company stock across two dates, April 2nd and April 6th, 2026. These sales included transactions to cover tax liabilities related to restricted stock units and another executed under a prearranged 10b5-1 trading plan. Despite the insider sales, Arteris stock is trading near its 52-week high after a significant 205% return over the past year, though InvestingPro analysis suggests it is currently trading above its Fair Value.
[144] Arteris, Inc. SEC Filing
This article reports on an SEC Form 144 filing by Arteris, Inc. (AIP) detailing a proposed sale of 1,552 shares by an individual. The filing indicates a neutral impact and sentiment, with the shares acquired through Restricted Stock Units on April 1, 2026. The proposed sale, valued at $28,246.40, is to be executed through Morgan Stanley Smith Barney LLC on NASDAQ.
Arteris, Inc. partners with Renesas to support R-Car Gen 5 automotive AI SoCs
Arteris, Inc. has announced a partnership with Renesas to enhance the development of next-generation automotive AI compute platforms. Arteris will provide its FlexNoC interconnect technology to support Renesas' R-Car Gen 5 system-on-chips, which are designed for high-performance automotive AI requirements. This collaboration highlights the growing need for advanced computing architectures in the automotive industry as AI capabilities continue to expand.
Arteris (NASDAQ:AIP) Shares Down 8.3% - Should You Sell?
Arteris (NASDAQ:AIP) shares dropped 8.3% during Monday's trading, despite the company beating quarterly EPS and revenue estimates. Analyst opinions are mixed, with a "Hold" consensus, and company insiders have recently sold a significant number of shares, though they still hold a substantial stake. Institutional investors have notably increased their holdings in the company.
AIP PE Ratio & Valuation, Is AIP Overvalued
This article provides a valuation analysis for Arteris Inc (AIP), indicating that the stock is currently in the "Fair zone" with a fair price range of $7.83 to $16.87 based on a relative valuation method. It compares AIP's current P/S ratio to its competitors, noting it's slightly above the industry average but sustainable due to robust revenue growth. The analysis also details various valuation metrics for AIP, such as P/B ratio, FCF yield, Forward P/E, and Forward P/S as of March 30, 2026.
Arteris CEO Janac sells $731k in AIP stock
K. Charles Janac, President and CEO of Arteris, Inc. (NASDAQ:AIP), sold 40,000 shares of company stock for approximately $731,623 in late March 2026. The sales occurred across two days, following a period of significant stock appreciation for Arteris. Despite recent positive earnings, an InvestingPro analysis suggests the stock may be overvalued.
Arteris CEO Sells $126,426 in Stock
Arteris, Inc. CEO K Charles Janac sold 7,012 shares of company stock for $126,426.36, decreasing his position by 0.08%. While insider selling can signal a lack of confidence, the motivations for Janac's sale, and several others he has made recently, are not fully clear. Arteris is a fabless semiconductor IP company, making investor sentiment around its technology and growth potential important.
Insider Selling: Arteris (NASDAQ:AIP) CEO Sells $126,426.36 in Stock
Arteris (NASDAQ:AIP) CEO K. Charles Janac sold 7,012 shares of the company's stock on March 25th for $126,426.36, reducing his stake by 0.08%. This recent sale is part of a series of transactions since January, totaling approximately $3.7 million. Arteris stock was down about 5.8% following the news, and analysts currently hold a consensus "Hold" rating with an average target price of $20.17.
Insider Selling: Arteris (NASDAQ:AIP) CEO Sells $605,329.80 in Stock
Arteris (NASDAQ:AIP) CEO K. Charles Janac sold 32,988 shares of company stock for $605,329.80 on March 26th, reducing his ownership by 0.36%. This sale is part of a pattern of frequent insider selling by Janac throughout the year. The company's stock traded down approximately 5.8% recently, holds a "Hold" consensus rating from analysts, and has a target price of $20.17 despite beating revenue and EPS estimates last quarter.
Arteris CEO Janac sells $731k in AIP stock
Arteris, Inc. President and CEO K. Charles Janac sold 40,000 shares of AIP stock for approximately $731,623 on March 25 and 26, 2026. The sales followed significant stock appreciation, with shares gaining 16% in the past week and 81% in the last six months. Janac's remaining holdings are substantial, and the company recently reported strong Q4 2025 earnings, exceeding revenue and EPS projections.
Arteris (AIP) CEO-linked LLC sells 40,000 shares under 10b5-1 plan
Arteris, Inc. President and CEO Charles K. Janac, through Bayview Legacy, LLC, sold 40,000 shares of Arteris common stock on March 25-26, 2026. The sales occurred at weighted average prices of $18.0309 and $18.3458 and were executed under a Rule 10b5-1 trading plan adopted in March 2025. Following these transactions, Bayview Legacy, LLC holds over 9 million shares, with Janac also holding shares directly and through a trust.
40K Arteris (AIP) shares sold by major holder Bayview Legacy LLC
Bayview Legacy, LLC, a major holder of Arteris, Inc. (AIP), sold 40,000 common shares over two transactions on March 25 and March 26, 2026. The sales were executed under a pre-arranged Rule 10b5-1 trading plan and occurred at weighted average prices of approximately $18.03 and $18.35 per share, respectively. Following these sales, Bayview Legacy, LLC still indirectly retains a substantial holding of over 9.1 million Arteris shares.
AMD Taps Arteris Technology for Next-Gen AI Chiplets
AMD has chosen Arteris' network-on-chip (NoC) interconnect technology for its next-generation AI chiplets. This collaboration aims to enhance the performance, power efficiency, and area optimization of AMD's advanced AI processors, leveraging Arteris' Ncore and FlexNoC technologies. The integration is expected to be crucial for developing competitive AI solutions.
AIP (NASDAQ: AIP) Form 144 shows proposed 20,000-share sale and Q1 2026 10b5-1 transfers
A Form 144 filing by Arteris, Inc. (NASDAQ: AIP) announces a proposed sale of 20,000 common shares valued at $359,800.00, referencing Morgan Stanley Smith Barney LLC Executive Financial Services and an effective date of March 26, 2026. The document also details previous 10b5-1 sales by BAYVIEW LEGACY, LLC and K. CHARLES JANAC during the first quarter of 2026, providing context for executed transactions and their proceeds. Analysts note the document records prior dispositions rather than new issuances and that the current filing does not specify who receives the proceeds from the proposed sale.
Arteris (NASDAQ:AIP) Trading 9.8% Higher - Still a Buy?
Arteris (NASDAQ:AIP) saw its shares jump by 9.8% to $18 on higher-than-average volume after beating quarterly earnings expectations. The company reported ($0.05) EPS against an estimate of ($0.08) and revenue of $20.14M compared to an $18.55M estimate. Despite the positive earnings, analysts are divided with an average "Hold" rating and a target price of $20.17, while insider selling has been noted alongside strong institutional ownership.
AIP (NASDAQ) insiders report 10b5-1 sales including 50,000-share trade
Arteris, Inc. (AIP) insiders, specifically BAYVIEW LEGACY, LLC and K. CHARLES JANAC, have reported multiple 10b5-1 stock sales, including a 50,000-share trade. The Form 144 filing indicates a proposed sale of 20,000 shares and details numerous executed dispositions with specific dates, share counts, and gross proceeds. These transactions are prearranged sales with various sizes, such as 50,000 shares on January 8, 2026, and 41,000 shares on March 9, 2026.
FastCompany selects Arteris, Inc. among Most Innovative Companies for 2026
Arteris, Inc. has been recognized by FastCompany's 2026 World’s Most Innovative Companies list, highlighting its commitment to innovation as a core product strategy. This distinction acknowledges the company's continuous advancement and creative solutions within its sector. Arteris, Inc. views this recognition as a reaffirmation of its approach to product development and growth.
Arteris joins Google and Nvidia on Fast Company's 2026 list
Arteris (Nasdaq: AIP) has been recognized on Fast Company’s World’s Most Innovative Companies of 2026 list, ranking #4 in North America. This acknowledgment highlights the company's commitment to innovation in semiconductor technology, particularly through its FlexGen smart NoC, multi-die/chiplet integration via Magillem Packaging, and the recent acquisition of Cycuity for semiconductor cybersecurity. The news has been met with a positive market reaction, with AIP stock gaining 6.58%.
Arteris Network-on-Chip IP Deployed in Renesas’ Next-Gen R-Car Automotive Technology
Arteris, Inc.'s FlexNoC network-on-chip (NoC) interconnect IP has been licensed and deployed by Renesas for its R-Car Gen 5 SoC series, designed for advanced driver-assistance and automated driving systems. This technology enables power-efficient, low-latency, and high-performance SoCs with functional safety support. The R-Car X5H SoC utilizes Arteris NoC IP to achieve high-speed image recognition and AI acceleration, while reducing power consumption and meeting automotive safety integrity level requirements.
Acuitas Investments LLC Sells 74,129 Shares of Arteris, Inc. $AIP
Acuitas Investments LLC significantly reduced its stake in Arteris, Inc. (NASDAQ:AIP) by 82.4% in Q3, selling 74,129 shares and retaining 15,871 shares valued at $160,000. This divestment occurred amidst notable insider selling from Director Saiyed Atiq Raza and CEO K Charles Janac, with insiders collectively selling 596,196 shares worth $9.66 million last quarter. Despite this, institutional ownership remains strong at 64.36%, and Arteris recently topped earnings estimates, trading near $15.46 with a consensus "Hold" rating and an average price target of $20.17.
Arteris (NASDAQ:AIP) Stock Rating Upgraded by Wall Street Zen
Wall Street Zen has upgraded Arteris (NASDAQ:AIP) stock rating from "hold" to "buy," although the overall analyst consensus remains a "Hold" with an average target price of $20.17. The company recently surpassed quarterly earnings estimates with an EPS of ($0.05) and revenue of $20.14 million. Despite institutional ownership of over 64% and insider ownership of 29.1%, there has been significant insider selling totaling nearly 600,000 shares in the last 90 days.
Arteris, Inc. (AIP) reports Q4 loss, beats revenue estimates
Arteris, Inc. (AIP) reported a wider-than-expected loss for the fourth quarter, with a loss of $0.14 per share compared to an estimated loss of $0.11 per share. However, the company surpassed revenue expectations, bringing in $14.1 million against an estimated $13.68 million. Despite the revenue beat, the stock experienced a slight dip of 0.28% in after-hours trading.
Arteris, Inc. (AIP) reports Q4 loss, beats revenue estimates
Arteris, Inc. reported a fourth-quarter loss but exceeded revenue estimates. This indicates a mixed financial performance with sales appearing stronger than profitability for the quarter.
Arteris (Nasdaq:AIP) - Stock Analysis
This Simply Wall St analysis provides a detailed overview of Arteris (Nasdaq:AIP), a semiconductor intellectual property solutions provider. The report covers the company's valuation, future growth prospects, past performance, financial health, and dividend policy, along with analyst consensus and recent news. Despite being currently unprofitable, Arteris is forecast for significant revenue growth, driven by AI adoption and chiplet architectures, and analysts anticipate a potential stock price increase.
Chiplet innovation isn’t waiting for perfect standards
The article discusses how chiplet technology is being adopted rapidly across various industries like AI, HPC, and automotive, even though universal standards are still in development. It highlights the advantages of chiplets over monolithic SoCs, such as better yields, cost reduction, and the ability to combine diverse process technologies. The author emphasizes that companies are progressing with chiplet innovation by using modular designs and automated integration, rather than waiting for fully mature standards.
Arteris, Inc. $AIP Shares Acquired by Granahan Investment Management LLC
Granahan Investment Management LLC significantly increased its stake in Arteris, Inc. (NASDAQ:AIP) by 725.7% during the third quarter of 2026, boosting its holdings to 621,625 shares valued at $6.278 million. This move indicates the institutional investor's strong confidence in Arteris's semiconductor intellectual property technology and future business prospects. The substantial acquisition could signal growing investor interest and positive outlook for the company.
Arteris, Inc. $AIP Shares Acquired by Granahan Investment Management LLC
Granahan Investment Management LLC significantly increased its stake in Arteris, Inc. (NASDAQ:AIP) by 725.7% during the 3rd quarter, now owning 1.42% of the company. Other institutional investors have also adjusted their positions in Arteris, which currently has a market capitalization of $665.23 million and a consensus analyst rating of "Hold." Recent insider transactions show major shareholders and the CEO selling shares, while analysts have a consensus price target of $20.17.
AIP SEC Filings - Arteris, Inc. 10-K, 10-Q, 8-K Forms
This page provides comprehensive access to Arteris, Inc. (AIP) SEC filings, including annual 10-K, quarterly 10-Q, and material event 8-K reports, as well as insider trading forms. It leverages AI-powered summaries to help investors quickly parse complex documents and monitor insider transactions. Recent filings detail insider sales by the COO and a Director, along with Form 144 filings regarding planned share dispositions.
Arteris (AIP) CEO sells 50,000 shares via Bayview Legacy 10b5-1 plan
Arteris, Inc. (AIP) President and CEO Charles K. Janac sold a total of 50,000 shares of common stock through Bayview Legacy, LLC on March 9-10, 2026. These sales, executed under a pre-arranged Rule 10b5-1 trading plan, occurred at weighted average prices of $14.2104 and $14.663 per share. After the transactions, Janac's indirect holdings via Bayview Legacy, LLC amounted to 9,229,071 shares, in addition to direct and trust holdings.
Why Arteris, Inc. (AIP) Is In Focus
Arteris, Inc. (AIP) is highlighted as a focus stock among small-cap semiconductor companies. Northland analyst Gus Richard reaffirmed a "top pick" rating and a $24 price target for AIP despite recent share pressure, following a strong Q4 2025 performance where the company exceeded revenue and EPS estimates. Arteris, a California-based provider of semiconductor system intellectual property solutions, projects substantial revenue growth for 2026.
Bayview Legacy LLC trims Arteris (AIP) stake with 50,000-share 10b5-1 sale
Bayview Legacy, LLC, a 10% owner of Arteris, Inc. (AIP), reported selling a total of 50,000 shares of common stock over two days, March 9 and March 10, 2026. These sales were conducted under a pre-arranged Rule 10b5-1 trading plan adopted by K. Charles Janac, who manages Bayview Legacy, LLC. Following these transactions, Bayview Legacy, LLC indirectly holds 9,229,071 Arteris common shares.
How Arteris Inc. (AIP) Affects Rotational Strategy Timing
This article analyzes Arteris Inc. (AIP) through the lens of a rotational strategy, highlighting a weak near-term sentiment that could precede shifts in its mid and long-term outlook. It identifies a strong risk-reward setup targeting a 16.9% gain with minimal risk, and details three AI-generated trading strategies: Position Trading, Momentum Breakout, and Risk Hedging, along with multi-timeframe signal analysis.
Arteris (NASDAQ:AIP) CEO K Charles Janac Sells 41,000 Shares
Arteris (NASDAQ:AIP) CEO K Charles Janac sold 41,000 shares of the company's stock on March 9th for over $582,000, reducing his stake by 0.44%. This sale is part of a larger pattern of insider selling by Janac since January, totaling approximately 189,000 shares. Despite the insider selling, Arteris shares traded up, and the company recently beat analyst estimates for EPS and revenue.
Arteris (NASDAQ:AIP) Major Shareholder Bayview Legacy, Llc Sells 41,000 Shares
Bayview Legacy, LLC, a major shareholder in Arteris (NASDAQ:AIP), sold 41,000 shares of the company's stock on March 9th for a total of $582,610. This transaction reduced Bayview Legacy's ownership by 0.44% and is part of a series of sales totaling approximately $2.66 million since early January. Arteris is currently trading near $15.62, with analysts holding a consensus "Hold" rating and an average price target of $20.17, despite the company slightly beating recent revenue and EPS estimates.
Arteris (NASDAQ:AIP) Major Shareholder Bayview Legacy, Llc Sells 9,000 Shares
Bayview Legacy, LLC, a major shareholder of Arteris (NASDAQ:AIP), sold 9,000 shares of the company's stock on March 10th at an average price of $14.66, reducing its stake by 0.10%. Despite this and other recent sales, Bayview Legacy still holds approximately 9.229 million shares. Arteris stock recently traded up 2.4% to $15.62, and the company reported a quarterly earnings beat and has a consensus "Hold" rating from analysts with a target price of $20.17.
Arteris (NASDAQ:AIP) CEO Sells $131,940.00 in Stock
Arteris (NASDAQ:AIP) CEO K Charles Janac sold 9,000 shares of the company's stock for $131,940 on March 10th. This sale is part of a series of large insider sales by Janac in recent months, reducing his stake by 0.10%, though he still holds over 9 million shares valued at approximately $135 million. Despite these sales, Arteris recently beat earnings estimates, and analysts have a consensus "Hold" rating with an average price target of $20.17.
Arteris Stock Pre-Market (-4.5%): Geopolitical Shock and Oil Spike Drive Risk-Off Sentiment
Arteris (NASDAQ: AIP) stock is down 4.5% in pre-market trading, reflecting a broader risk-off sentiment in the market. This downturn is primarily attributed to geopolitical tensions and a significant spike in oil prices.
7 Small-Cap Semiconductor Stocks to Buy According to Analysts
This article identifies Arteris, Inc. (NASDAQ:AIP) as one of seven small-cap semiconductor stocks recommended by analysts. Northland analyst Gus Richard reiterated Arteris as a "top pick" for 2026 with a $24 price target, despite recent stock pressure. Arteris exceeded Q4 2025 revenue and EPS estimates and projects strong revenue growth for 2026.
7 Small-Cap Semiconductor Stocks to Buy According to Analysts
Arteris, Inc. (NASDAQ:AIP) is highlighted as a top pick for 2026 by Northland analyst Gus Richard, despite recent stock pressure following an ATM announcement. The company exceeded Q4 2025 revenue and EPS estimates, driven by a record-breaking quarter in bookings. Arteris projects strong revenue growth for 2026, solidifying its positive outlook.
Trust tied to Arteris (AIP) director sells 109,721 shares under 10b5‑1 plan
A trust associated with Arteris (AIP) director Saiyed Atiq Raza sold a total of 109,721 common shares in early March 2026 under a pre-arranged 10b5-1 trading plan. The sales occurred on March 2nd and March 4th at weighted average prices around $17 per share. Following these transactions, the trust indirectly holds 390,000 shares, and Raza directly holds 20,839 shares.
Saiyed Atiq Raza Sells 3,690 Shares of Arteris (NASDAQ:AIP) Stock
Arteris director Saiyed Atiq Raza sold 3,690 shares of Arteris (NASDAQ:AIP) stock on March 4th for $62,803.80, reducing his direct ownership to 390,000 shares. This follows multiple insider sales in late February and early March totaling approximately $3.43 million. The company's shares traded up 1.7% to $16.46, and it recently beat modest quarterly EPS and revenue estimates, with analysts maintaining a consensus "Hold" rating and an average target price near $20.17.
Arteris (NASDAQ:AIP) Director Saiyed Atiq Raza Sells 106,031 Shares
Arteris (NASDAQ:AIP) Director Saiyed Atiq Raza recently sold 106,031 shares of company stock for over $1.82 million, bringing his total sales across five trades from February 25 to March 4 to 200,000 shares worth approximately $3.43 million. These transactions reduced his direct ownership by over 21% to 393,690 shares. The company's stock traded up 1.7% and recently beat quarterly EPS and revenue estimates, with analysts currently holding a consensus "Hold" rating and a average price target of $20.17.
ARTERIS NETWORK-ON-CHIP TECHNOLOGY SURPASSES 4 BILLION DEVICES
Arteris Inc. announced that its network-on-chip (NoC) interconnect intellectual property (IP) has shipped in over four billion devices globally, a significant milestone driven by the increasing adoption of AI-enabled systems. This achievement highlights the essential role of Arteris's data movement technology in modern system design, especially as AI systems become more complex and distributed. The company's NoC technology is critical for managing compute density, energy efficiency, and chiplet integration across various sectors including automotive, enterprise computing, and consumer electronics.
